These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 20041446

  • 21. Toxicogenomics concepts and applications to study hepatic effects of food additives and chemicals.
    Stierum R, Heijne W, Kienhuis A, van Ommen B, Groten J.
    Toxicol Appl Pharmacol; 2005 Sep 01; 207(2 Suppl):179-88. PubMed ID: 16139318
    [Abstract] [Full Text] [Related]

  • 22. Genomic and proteomic profiling for biomarkers and signature profiles of toxicity.
    Merrick BA, Bruno ME.
    Curr Opin Mol Ther; 2004 Dec 01; 6(6):600-7. PubMed ID: 15663324
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Application of toxicogenomics to genetic toxicology risk assessment.
    Thybaud V, Le Fevre AC, Boitier E.
    Environ Mol Mutagen; 2007 Jun 01; 48(5):369-79. PubMed ID: 17567850
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Application of toxicogenomics to drug development.
    Lakkis MM, DeCristofaro MF, Ahr HJ, Mansfield TA.
    Expert Rev Mol Diagn; 2002 Jul 01; 2(4):337-45. PubMed ID: 12138498
    [Abstract] [Full Text] [Related]

  • 27. Application of genomics in preclinical drug safety evaluation.
    Lord PG, Nie A, McMillian M.
    Basic Clin Pharmacol Toxicol; 2006 Jun 01; 98(6):537-46. PubMed ID: 16700814
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Toxicogenomics: transcription profiling for toxicology assessment.
    Zhou T, Chou J, Watkins PB, Kaufmann WK.
    EXS; 2009 Jun 01; 99():325-66. PubMed ID: 19157067
    [Abstract] [Full Text] [Related]

  • 30. Prediction model of potential hepatocarcinogenicity of rat hepatocarcinogens using a large-scale toxicogenomics database.
    Uehara T, Minowa Y, Morikawa Y, Kondo C, Maruyama T, Kato I, Nakatsu N, Igarashi Y, Ono A, Hayashi H, Mitsumori K, Yamada H, Ohno Y, Urushidani T.
    Toxicol Appl Pharmacol; 2011 Sep 15; 255(3):297-306. PubMed ID: 21784091
    [Abstract] [Full Text] [Related]

  • 31. A decade of toxicogenomic research and its contribution to toxicological science.
    Chen M, Zhang M, Borlak J, Tong W.
    Toxicol Sci; 2012 Dec 15; 130(2):217-28. PubMed ID: 22790972
    [Abstract] [Full Text] [Related]

  • 32. Applications of emerging technologies in toxicology and safety assessment.
    Reynolds VL.
    Int J Toxicol; 2005 Dec 15; 24(3):135-7. PubMed ID: 16040564
    [Abstract] [Full Text] [Related]

  • 33. A toxicogenomics-based parallelogram approach to evaluate the relevance of coumarin-induced responses in primary human hepatocytes in vitro for humans in vivo.
    Kienhuis AS, van de Poll MC, Dejong CH, Gottschalk R, van Herwijnen M, Boorsma A, Kleinjans JC, Stierum RH, van Delft JH.
    Toxicol In Vitro; 2009 Sep 15; 23(6):1163-9. PubMed ID: 19527782
    [Abstract] [Full Text] [Related]

  • 34. Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development.
    Blomme EA, Yang Y, Waring JF.
    Toxicol Lett; 2009 Apr 10; 186(1):22-31. PubMed ID: 18996174
    [Abstract] [Full Text] [Related]

  • 35. Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix database.
    Ganter B, Snyder RD, Halbert DN, Lee MD.
    Pharmacogenomics; 2006 Oct 10; 7(7):1025-44. PubMed ID: 17054413
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Toxicogenomics and systems toxicology: aims and prospects.
    Waters MD, Fostel JM.
    Nat Rev Genet; 2004 Dec 10; 5(12):936-48. PubMed ID: 15573125
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Pharmacogenomic approaches in clinical studies to identify biomarkers of safety and efficacy.
    Burczynski ME.
    Toxicol Lett; 2009 Apr 10; 186(1):18-21. PubMed ID: 19022363
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.